Multiple Myeloma Research Foundation logo
Myeloma Investment Fund (MIF)

Myeloma Investment Fund (MIF)

Invests in early-stage multiple myeloma drug and technology companies, recycling returns into further health innovation investments.

OpenMultiple Myeloma Research FoundationUnited States
View on funder site
About

The Myeloma Investment Fund (MIF) is a wholly-owned evergreen venture philanthropy subsidiary of the Multiple Myeloma Research Foundation (MMRF), established in 2019 to make equity investments in early-stage biotechnology companies developing novel myeloma therapies and technologies. MIF has committed USD 23 million across 21 portfolio companies since founding, with 17 companies currently active a…

What this grant funds

Evergreen venture-philanthropy equity fund investing in early-stage biotech companies developing novel multiple myeloma therapies and technologies, with all returns reinvested into the fund.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.Rolling
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Equity
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.$23M
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
Last verified: 24 Jul 2026Source: myelomainvestmentfund.org